[1] Pezeshki M, Ansari J, Esfandyari M, Tamjidi E, Ahmadi A, Komijani D. Investigating the Importance of the Role of Key Genes in the Diagnosis and Treatment of Lung Cancer: A Review Article. Paramedical Sciences and Military Health. 2023 Oct 10;18(1):61-77. [Link] [2] Pezeshki M, Hosseini SM, Ansari J, Ahmadi A. Investigating the importance of Exo1 (K589E) and LEP (− 2548G/A) gene polymorphisms with risk of lung cancer as potential diagnostic biomarker in Iranian population. Egyptian Journal of Medical Human Genetics. 2023 Sep 23;24(1):55. [link]
[3] Grenda A, Błach J, Szczyrek M, Krawczyk P, Nicoś M, Kuźnar Kamińska B, Jakimiec M, Balicka G, Chmielewska I, Batura‐Gabryel H, Sawicki M. Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients. Cancer Medicine. 2020 Jan;9(2):605-14. [10.1002/cam4.2743 ] [PMID]
[4] Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP, Enyioha C, Malo TL, Brenner AT, Armstrong C, Coker-Schwimmer M. Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force. Jama. 2021 Mar 9;325(10):971-87. [10.1001/jama.2021.0377 ] [PMID]
[5] Chetan MR, Gleeson FV. Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives. European radiology. 2021 Feb;31:1049-58. [10.1007 / s00330-020-07141-9 ] [PMID]
[6] Bab S, Abdifard E, Moradi Y, Faraj A, Heidari M. Lung cancer incidence trends in Iran and in six geographical regions of the country (2000-2005). Shiraz E Medical Journal. 2016;17(6). [Link]
[7] Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, Chirieac LR, Dacic S, Duhig E, Flieder DB, Geisinger K. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. Journal of thoracic oncology. 2015 Sep 1;10(9):1243-60. [10.1097/JTO.0000000000000630 ] [PMID]
[8] Rahal Z, El Nemr S, Sinjab A, Chami H, Tfayli A, Kadara H. Smoking and lung cancer: a geo-regional perspective. Frontiers in oncology. 2017 Sep 1;7:194. [10.3389/fonc.2017.00194 ] [PMID]
[9] Yang IA, Holloway JW, Fong KM. Genetic susceptibility to lung cancer and co-morbidities. Journal of thoracic disease. 2013 Oct;5(Suppl 5):S454. [10.3978/j.issn.2072-1439.2013.08.06 ] [PMID]
[10] Torres-Jasso JH, Marín ME, Santiago-Luna E, Leoner JC, Torres J, Magaña-Torres MT, Perea FJ, Ibarra B, Sánchez-López JY. EGFR gene polymorphisms-216G> T and-191C> A are risk markers for gastric cancer in Mexican population. Genetics and Molecular Research. 2015 Mar 13;14(1):1802-7. [10.4238/ 2015.March.13.8 ] [PMID]
[11] Stoehlmacher-Williams J, Obermann L, Ehninger G, Goekkurt E. Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC). Anticancer research. 2012 Feb 1;32(2):421-5. [PMID]
)